HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe depressive mood changes following slow-release intramuscular fluphenazine injection.

Abstract
Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection. In five cases this depression is thought to have been responsible for suicide. In 8 out of 10 cases the depression responded to electroplexy (E.C.T.). It is recommended that patients who are treated with fluphenazine should be carefully supervised.
AuthorsR De Alarcon, M W Carney
JournalBritish medical journal (Br Med J) Vol. 3 Issue 5670 Pg. 564-7 (Sep 06 1969) ISSN: 0007-1447 [Print] England
PMID5808010 (Publication Type: Journal Article)
Chemical References
  • Delayed-Action Preparations
  • Fluphenazine
Topics
  • Adult
  • Delayed-Action Preparations
  • Depression (chemically induced)
  • Electroconvulsive Therapy
  • Female
  • Fluphenazine (adverse effects)
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Schizophrenia (drug therapy)
  • Suicide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: